Inicio › Linfoma difuso de células B grandes › Nueva York › New York City
Ensayos clínicos de Linfoma difuso de células B grandes en New York City, NY
21 estudios para Linfoma difuso de células B grandes buscan participantes en centros de New York City y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
ReclutandoFase 1/2
- Columbia University Medical Center, New York
- Weill Cornell Medical College Newyork Presbyterian Hospital, New York
- Memorial Sloan Kettering Cancer Center Mskcc, New York
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
ReclutandoFase 2
- Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
ReclutandoFase 3
- Icahn School of Medicine at Mount Sinai ( Site 0164), New York
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
ReclutandoFase 2
- Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 0108), New York
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
ReclutandoFase 1
- New York University (NYU) Clinical Cancer Center, New York
- Weill Cornell Medicine, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
ReclutandoFase 1
- Columbia University, New York
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
ReclutandoFase 1/2
- Memorial Sloan Kettering Cancer Center ( Site 1010), New York
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
ReclutandoFase 1
- Memorial Sloan Kettering Cancer Center, New York
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
ReclutandoFase 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
A Study of ARC-02 in B-cell NHL
ReclutandoFase 1
- NYU Langone, New York
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
ReclutandoFase 1/2
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma
ReclutandoFase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
DALY II USA/ MB-CART2019.1 for DLBCL
ReclutandoFase 2
- Memorial Sloan Kettering Cancer Center, New York
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
ReclutandoFase 1
- Memorial Sloan Kettering Cancer Center, New York
Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma
ReclutandoFase 1 temprana
- Memorial Sloan Kettering Cancer Center, New York
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
ReclutandoFase 2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
Reclutando
- Columbia University, New York
A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
ReclutandoFase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
ReclutandoFase 2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
Reclutando
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
- NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only), New York
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
ReclutandoFase 2
- Memorial Sloan Kettering Cancer Center, New York
Ensayos de Linfoma difuso de células B grandes en otras ciudades
- Baldwin Park, CA19 estudios
- Chicago, IL18 estudios
- Houston, TX17 estudios
- Los Angeles, CA17 estudios
- Milwaukee, WI16 estudios
- Boston, MA16 estudios
- Nashville, TN15 estudios
- Philadelphia, PA15 estudios
- Portland, OR15 estudios
- Durham, NC14 estudios
- Dallas, TX13 estudios
- Washington, DC12 estudios
Otros estudios en New York City
- Cáncer de seno136 estudios
- Cáncer de pulmón de células no pequeñas121 estudios
- Cáncer (todos los tipos)109 estudios
- Cáncer de próstata103 estudios
- Cáncer metastásico93 estudios
- Cáncer del colon y del recto78 estudios
- Cáncer de ovario69 estudios
- Cáncer de pulmón60 estudios
- Mieloma múltiple60 estudios
- Cáncer de páncreas60 estudios
- Cáncer de endometrio52 estudios
- Leucemia mielógena aguda51 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.